 Cholesterol lipid disturbances renal disease natural history uremic dyslipidemia impact hemodialysis continuous ambulatory peritoneal dialysis Lipid abnormalities renal insufficiency mechanism analogous majority patients chronic renal failure die cardiovascular complications Lipid abnormalities group high mortality causal association dyslipidemia accelerated atherosclerosis end-stage renal disease population presence pro-atherogenic conditions population current study lipid data renal population years report main parts first survey lipid levels atherogenicity indicators groups different types renal disease modalities treatment second multivariate analysis relationship clinical biochemical variables interactions serum lipid apolipoprotein levels ratios change time large dialysis population third study peritoneal clearances apolipoproteins A-I patients continuous ambulatory peritoneal dialysis relationship clearances lipid lipoprotein levels risk ratios